Opening https://www.globenewswire.com/news-release/2023/03/16/2628523/0/en/Alterity-Therapeutics-Enrolls-First-Patient-in-the-U-S-in-ATH434-Phase-2-Clinical-Trial-in-Multiple-System-Atrophy.html